Profile
Full Name
BridgeBio Pharma, Inc.Ticker
NASDAQ: BBIOExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
June 27, 2019Indexes
Not includedWebsite
http://bridgebio.comEmployees
725Key Details
Price
$45.94(+0.61%)
Market cap
$8.72B(Mid cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$221.90M(+2285.27% YoY)
Annual EPS
-$2.88(+27.09% YoY)
Next earnings date
Aug 5, 2025Next ex-dividend date
N/ANext split date
N/AQuick Search
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Analyst ratings
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
BridgeBio Pharma, Inc. doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Jul 14, 25 Piper Sandler
OverweightJul 14, 25 Jefferies
BuyJul 11, 25 Citigroup
BuyJul 9, 25 Oppenheimer
OutperformJun 30, 25 Wells Fargo
OverweightJun 25, 25 B of A Securities
BuyJun 17, 25 Wolfe Research
OutperformJun 9, 25 HC Wainwright & Co.
BuyApr 30, 25 UBS
BuyApr 30, 25 Scotiabank
Sector OutperformInstitutional Ownership
- What is the ticker symbol for BridgeBio Pharma, Inc.?
- Does BridgeBio Pharma, Inc. pay dividends?
- What sector is BridgeBio Pharma, Inc. in?
- What industry is BridgeBio Pharma, Inc. in?
- What country is BridgeBio Pharma, Inc. based in?
- When did BridgeBio Pharma, Inc. go public?
- Is BridgeBio Pharma, Inc. in the S&P 500?
- Is BridgeBio Pharma, Inc. in the NASDAQ 100?
- Is BridgeBio Pharma, Inc. in the Dow Jones?
- When was BridgeBio Pharma, Inc.'s last earnings report?
- When does BridgeBio Pharma, Inc. report earnings?
What is the ticker symbol for BridgeBio Pharma, Inc.?
The ticker symbol for BridgeBio Pharma, Inc. is NASDAQ:BBIO
Does BridgeBio Pharma, Inc. pay dividends?
No, BridgeBio Pharma, Inc. does not pay dividends
What sector is BridgeBio Pharma, Inc. in?
BridgeBio Pharma, Inc. is in the Healthcare sector
What industry is BridgeBio Pharma, Inc. in?
BridgeBio Pharma, Inc. is in the Biotechnology industry
What country is BridgeBio Pharma, Inc. based in?
BridgeBio Pharma, Inc. is headquartered in United States
When did BridgeBio Pharma, Inc. go public?
BridgeBio Pharma, Inc.'s initial public offering (IPO) was on June 27, 2019
Is BridgeBio Pharma, Inc. in the S&P 500?
No, BridgeBio Pharma, Inc. is not included in the S&P 500 index
Is BridgeBio Pharma, Inc. in the NASDAQ 100?
No, BridgeBio Pharma, Inc. is not included in the NASDAQ 100 index
Is BridgeBio Pharma, Inc. in the Dow Jones?
No, BridgeBio Pharma, Inc. is not included in the Dow Jones index
When was BridgeBio Pharma, Inc.'s last earnings report?
BridgeBio Pharma, Inc.'s most recent earnings report was on April 29, 2025
When does BridgeBio Pharma, Inc. report earnings?
The next expected earnings date for BridgeBio Pharma, Inc. is August 5, 2025